skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
17785511
Filing Dt:
06/15/2022
Publication #:
Pub Dt:
05/11/2023
Inventors:
Edward AINSCOW, Ashwani BAHL, Mihiro SUNOSE, Damien Francis Philippe CREPIN et al
Title:
4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AND THEIR THERAPEUTIC USE
Assignment: 1
Reel/Frame:
060392/0493Recorded: 06/22/2022Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/14/2021
Exec Dt:
01/12/2021
Exec Dt:
01/12/2021
Exec Dt:
01/13/2021
Exec Dt:
01/13/2021
Assignee:
THE DISCOVERY BUILDING, BIOCITY
PENNYFOOT STREET, NOTTINGHAM
NOTTINGHAMSHIRE, UNITED KINGDOM NG1 1GR
Correspondent:
ADSERO IP
8210 SOUTHPARK TERRACE
LITTLETON, CO 80120
Assignment: 2
Reel/Frame:
064888/0608Recorded: 09/13/2023Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/20/2021
Assignee:
10 EARLSFORT TERRACE
DUBLIN 2, IRELAND D02 T380
Correspondent:
EVAN A. DAVEY
FISH & RICHARDSON P.C.
P.O.BOX 1022
MINNEAPOLIS, MN 55440-1022
Assignment: 3
Reel/Frame:
060392/0501Recorded: 06/22/2022Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/27/2021
Exec Dt:
01/27/2021
Exec Dt:
01/20/2021
Assignee:
10 EARLSFORT TERRACE
DUBLIN 2, IRELAND D02 T380
Correspondent:
ADSERO IP
8210 SOUTHPARK TERRACE
LITTLETON, CO 80120

Search Results as of: 05/25/2024 08:24 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT